Geode Capital Management
ARCT icon

Geode Capital Management’s Arcturus Therapeutics ARCT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$7.89M Buy
606,291
+36,671
+6% +$477K ﹤0.01% 2498
2025
Q1
$6.03M Buy
569,620
+14,636
+3% +$155K ﹤0.01% 2570
2024
Q4
$9.42M Buy
554,984
+3,186
+0.6% +$54.1K ﹤0.01% 2416
2024
Q3
$12.8M Buy
551,798
+5,789
+1% +$134K ﹤0.01% 2229
2024
Q2
$13.3M Sell
546,009
-4,254
-0.8% -$104K ﹤0.01% 2154
2024
Q1
$18.6M Buy
550,263
+11,998
+2% +$405K ﹤0.01% 1965
2023
Q4
$17M Buy
538,265
+26,097
+5% +$823K ﹤0.01% 2013
2023
Q3
$13.1M Buy
512,168
+16,992
+3% +$434K ﹤0.01% 2093
2023
Q2
$14.2M Buy
495,176
+27,060
+6% +$776K ﹤0.01% 2078
2023
Q1
$11.2M Buy
468,116
+18,177
+4% +$436K ﹤0.01% 2191
2022
Q4
$7.63M Buy
449,939
+33,148
+8% +$562K ﹤0.01% 2436
2022
Q3
$6.18M Buy
416,791
+24,254
+6% +$359K ﹤0.01% 2556
2022
Q2
$6.18M Buy
392,537
+21,554
+6% +$339K ﹤0.01% 2579
2022
Q1
$10M Sell
370,983
-4,130
-1% -$111K ﹤0.01% 2343
2021
Q4
$13.9M Sell
375,113
-25,256
-6% -$935K ﹤0.01% 2217
2021
Q3
$19.1M Buy
400,369
+16,752
+4% +$800K ﹤0.01% 1986
2021
Q2
$13M Buy
383,617
+27,721
+8% +$938K ﹤0.01% 2281
2021
Q1
$14.7M Buy
355,896
+31,500
+10% +$1.3M ﹤0.01% 2081
2020
Q4
$14.1M Buy
324,396
+54,862
+20% +$2.38M ﹤0.01% 1930
2020
Q3
$11.6M Buy
269,534
+57,333
+27% +$2.46M ﹤0.01% 1857
2020
Q2
$9.92M Buy
212,201
+123,714
+140% +$5.78M ﹤0.01% 1924
2020
Q1
$1.2M Buy
88,487
+3,992
+5% +$54.2K ﹤0.01% 2933
2019
Q4
$918K Buy
84,495
+5,745
+7% +$62.4K ﹤0.01% 3307
2019
Q3
$808K Buy
78,750
+65,277
+485% +$670K ﹤0.01% 3306
2019
Q2
$127K Buy
+13,473
New +$127K ﹤0.01% 3902
2017
Q4
Sell
-11,033
Closed -$11K 4025
2017
Q3
$11K Hold
11,033
﹤0.01% 4036
2017
Q2
$12K Sell
11,033
-4,711
-30% -$5.12K ﹤0.01% 4069
2017
Q1
$17K Buy
15,744
+642
+4% +$693 ﹤0.01% 4048
2016
Q4
$31K Buy
15,102
+428
+3% +$879 ﹤0.01% 3971
2016
Q3
$36K Buy
14,674
+107
+0.7% +$263 ﹤0.01% 3947
2016
Q2
$65K Hold
14,567
﹤0.01% 3883
2016
Q1
$55 Buy
+14,567
New +$55 ﹤0.01% 3954